Gossamer Bio (NASDAQ:GOSS) Stock, Quote.MetaTitle.unusual-options

Gossamer Bio

Aperçu

Actualités

Gains

Options

Évaluations des analystes

Transactions internes

Intérêt court

Rapport sur les stocks

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Comments

Gossamer Bio Options Inhabitueles

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL